Read + Share
Dieci MV, Vernaci G, Colangelo C, Bria E, et al. PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2-
metastatic breast cancer: A multicentric real-world study. Eur J Cancer 2025;234:116194.
PMID: 41435752
|
 |
|
Dieci MV, Vernaci G, Colangelo C, Bria E, et al. PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2-
metastatic breast cancer: A multicentric real-world study. Eur J Cancer 2025;234:116194.
PMID: 41435752
|
|
|
|